H.C. Wainwright Reiterates Neutral Rating on Inhibikase Therapeutics Inc (IKT)

Go back to H.C. Wainwright Reiterates Neutral Rating on Inhibikase Therapeutics Inc (IKT)
(NASDAQ: IKT) Delayed: 2.26 +0.08 (3.67%)
Previous Close $2.18    52 Week High
Open $2.19    52 Week Low
Day High $2.29    P/E N/A 
Day Low $2.16    EPS
Volume 161,223